Skip to main content
. 2016 Jun 15;17(6):944. doi: 10.3390/ijms17060944
AML Acute myeloid leukemia
ATG Anti-thymocyte globulin
ERVs Endogenous retroviruses
FasL Fas ligand
FasR Fas receptor
HMA Hypomethylating agent ICUS Idiopathic cytopenia of undetermined significance
IDO Indoleamine 2,3-dioxygenase
IFN-γ Interferon-γ IPSS International Prognostic Scoring System
IPSS-R Revised International Prognostic Scoring System
ITP Idiopathic thrombocytopenic purpura
MAPK Mitogen-activated protein kinase
MDS Myelodysplastic syndrome MHC Major histocompatibility complex MMF Mycophenolate Mofetil
MSC Mesenchymal stromal cells
NF-κB Nuclear factor k-light-chain-enhancer of activated B cells
NSAIDs Non-steroidal anti-inflammatory drugs
RA Refactory anemia
RCMD Refractory anemia with multilineage dysplasia
TCR T-cell receptor
TNF-α Tumor necrosis factor α
TRAIL Tumor necrosis factor–related apoptosis-inducing ligand